DE69429522D1 - Injizierbare zusammensetzungen zur vergrösserung von weichgewebe - Google Patents

Injizierbare zusammensetzungen zur vergrösserung von weichgewebe

Info

Publication number
DE69429522D1
DE69429522D1 DE69429522T DE69429522T DE69429522D1 DE 69429522 D1 DE69429522 D1 DE 69429522D1 DE 69429522 T DE69429522 T DE 69429522T DE 69429522 T DE69429522 T DE 69429522T DE 69429522 D1 DE69429522 D1 DE 69429522D1
Authority
DE
Germany
Prior art keywords
soft tissue
injectable compositions
tissue augmentation
injectable implant
enlarge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69429522T
Other languages
English (en)
Other versions
DE69429522T2 (de
Inventor
Ernst Janzen
Matthias Johannes Hoekstra
Richard P Dutrieux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Datascope Investment Corp
Original Assignee
Datascope Investment Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Datascope Investment Corp filed Critical Datascope Investment Corp
Application granted granted Critical
Publication of DE69429522D1 publication Critical patent/DE69429522D1/de
Publication of DE69429522T2 publication Critical patent/DE69429522T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69429522T 1993-09-07 1994-09-07 Injizierbare zusammensetzungen zur vergrösserung von weichgewebe Expired - Lifetime DE69429522T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/116,517 US5523291A (en) 1993-09-07 1993-09-07 Injectable compositions for soft tissue augmentation
PCT/US1994/010223 WO1995007095A1 (en) 1993-09-07 1994-09-07 Injectable compositions for soft tissue augmentation

Publications (2)

Publication Number Publication Date
DE69429522D1 true DE69429522D1 (de) 2002-01-31
DE69429522T2 DE69429522T2 (de) 2002-08-01

Family

ID=22367654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69429522T Expired - Lifetime DE69429522T2 (de) 1993-09-07 1994-09-07 Injizierbare zusammensetzungen zur vergrösserung von weichgewebe

Country Status (13)

Country Link
US (2) US5523291A (de)
EP (1) EP0717634B1 (de)
KR (1) KR100333088B1 (de)
CN (1) CN1142789C (de)
AT (1) ATE210992T1 (de)
AU (1) AU675879B2 (de)
BR (1) BR9407420A (de)
CA (1) CA2170754C (de)
DE (1) DE69429522T2 (de)
DK (1) DK0717634T3 (de)
ES (1) ES2169085T3 (de)
PT (1) PT717634E (de)
WO (1) WO1995007095A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606019A (en) * 1987-10-29 1997-02-25 Protien Polymer Technologies, Inc. Synthetic protein as implantables
US6537574B1 (en) 1992-02-11 2003-03-25 Bioform, Inc. Soft tissue augmentation material
US7060287B1 (en) * 1992-02-11 2006-06-13 Bioform Inc. Tissue augmentation material and method
US7968110B2 (en) * 1992-02-11 2011-06-28 Merz Aesthetics, Inc. Tissue augmentation material and method
US5676698A (en) * 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
US5523291A (en) * 1993-09-07 1996-06-04 Datascope Investment Corp. Injectable compositions for soft tissue augmentation
US6334872B1 (en) * 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
US20020095218A1 (en) 1996-03-12 2002-07-18 Carr Robert M. Tissue repair fabric
US5993844A (en) * 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US6371992B1 (en) * 1997-12-19 2002-04-16 The Regents Of The University Of California Acellular matrix grafts: preparation and use
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
AU763724B2 (en) * 1998-06-05 2003-07-31 Duke University School Of Medicine Bioengineered vascular graft support prostheses
WO1999063051A2 (en) * 1998-06-05 1999-12-09 Organogenesis Inc. Bioengineered flat sheet graft prostheses
MXPA00012061A (es) * 1998-06-05 2003-04-22 Organogenesis Inc Protesis de injerto vascular biodisenadas.
ATE423577T1 (de) * 1998-06-05 2009-03-15 Organogenesis Inc Biologisch modellierte implantierbare prothesen
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
WO2000051676A1 (en) * 1999-03-01 2000-09-08 Advanced Biomedical Devices, Inc. Implant positioning system and method
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
CA2777791A1 (en) * 2000-09-18 2002-03-21 Organogenesis Inc. Methods for treating a patient using a bioengineered flat sheet graft prostheses
KR100514582B1 (ko) * 2001-09-05 2005-09-13 한스바이오메드 주식회사 생체복원물질의 제조방법
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
WO2004047622A2 (en) * 2002-11-26 2004-06-10 Crosscart, Inc. Substantially non-immunogenic injectable collagen
WO2004060425A2 (en) * 2002-12-27 2004-07-22 Angiotech International Ag Compositions and methods of using collagen and mmpi
US8137688B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) * 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8138265B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
FR2850282B1 (fr) * 2003-01-27 2007-04-06 Jerome Asius Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
EP2193812A1 (de) * 2003-09-19 2010-06-09 Broockeville Corporation N.V. Verwendung eines härtbaren Elastomer-Precusors in einer medizinischen Behandlung
US7597660B2 (en) * 2003-09-19 2009-10-06 Broockeville Corporation B.V. Incontinence therapy
US20050148512A1 (en) * 2003-11-10 2005-07-07 Angiotech International Ag Medical implants and fibrosis-inducing agents
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US20050209695A1 (en) * 2004-03-15 2005-09-22 De Vries Jan A Vertebroplasty method
US20050228216A1 (en) * 2004-04-08 2005-10-13 Vries Jan A D Method for treating gastroesophageal reflux disease
CN1294994C (zh) * 2004-07-05 2007-01-17 暨南大学 可注射型胶原基软组织填充材料及其制备方法
US9788821B2 (en) * 2005-04-29 2017-10-17 Cook Biotech Incorporated Physically modified extracellular matrix materials and uses thereof
CN101252957A (zh) * 2005-06-30 2008-08-27 人类起源公司 使用胎盘源胶原生物纤维的鼓膜修复
US20070184087A1 (en) 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
GB0618215D0 (en) * 2006-09-15 2006-10-25 Novathera Ltd Composite material
US20080131522A1 (en) * 2006-10-03 2008-06-05 Qing Liu Use of placental biomaterial for ocular surgery
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
KR20210018526A (ko) 2006-10-06 2021-02-17 안트로제네시스 코포레이션 천연(텔로펩티드) 태반 콜라겐 조성물
CN101553262A (zh) 2006-11-13 2009-10-07 悉尼大学 原弹性蛋白用于组织修复或恢复的用途
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US20100179639A1 (en) * 2007-04-16 2010-07-15 Stephen Bloor Vascular implant
AU2008237740B2 (en) * 2007-04-16 2014-02-06 Covidien Ag Bone implant
AU2008282922B2 (en) * 2007-07-27 2014-01-16 Humacyte, Inc. Compositions comprising human collagen and human elastin and methods for soft tissue augmentation
EP2249891B1 (de) * 2008-02-13 2016-05-25 The Cleveland Clinic Foundation Molekulare verstärkung von extrazellulärer matrix und anwendungsverfahren
KR100947553B1 (ko) * 2008-02-14 2010-03-12 주식회사 바이오랜드 생체조직 이식재 및 그의 제조 방법
EP2300042A4 (de) * 2008-04-30 2012-05-02 Cleveland Clinic Foundation Zusammensetzungen und verfahren zur behandlung von harninkontinenz
CA2734560C (en) * 2008-06-20 2018-10-23 Cook Biotech Incorporated Composite extracellular matrix materials and medical products formed therefrom
US9248165B2 (en) 2008-11-05 2016-02-02 Hancock-Jaffe Laboratories, Inc. Composite containing collagen and elastin as a dermal expander and tissue filler
CA2762212C (en) * 2009-05-20 2015-12-29 Humacyte, Inc. Elastin for soft tissue augmentation
US8252022B2 (en) * 2009-07-13 2012-08-28 Vascular Solutions, Inc. Metal vascular aperture closure device
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US20130011451A1 (en) 2011-07-06 2013-01-10 Diversified Glogal Technologies, Llc Footbed with non-denatured collagen
KR20220093383A (ko) * 2014-02-11 2022-07-05 안트로제네시스 코포레이션 마이크로-오가노이드, 및 이의 제조방법 및 사용방법
US9993578B1 (en) * 2017-01-12 2018-06-12 Lorstan Pharmaceutical, LLC Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4488911A (en) * 1975-10-22 1984-12-18 Luck Edward E Non-antigenic collagen and articles of manufacture
US4233360A (en) * 1975-10-22 1980-11-11 Collagen Corporation Non-antigenic collagen and articles of manufacture
CA1073360A (en) * 1975-10-22 1980-03-11 John R. Daniels Non-antigenic collagen and articles of manufacture
DE2705670C3 (de) * 1977-02-11 1983-11-17 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von wasserlöslichen Elastin-Hydrolysaten
CA1190855A (en) * 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
US4378224A (en) * 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
US4960423A (en) * 1982-11-17 1990-10-02 Smith Donald W Method of enhancing the attachment of endothelial cells on a matrix and vascular prosthesis with enhanced anti-thrombogenic characteristics
US4692552A (en) * 1983-05-09 1987-09-08 G. D. Searle & Co. Protease inhibitors
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4601896A (en) * 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
US4642117A (en) * 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4649147A (en) * 1985-07-08 1987-03-10 G. D. Searle & Co. Treating elastin degradation with 1-(alkenoyl)azacycloalkyl carboxylic acids and derivatives
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
GB8708009D0 (en) * 1987-04-03 1987-05-07 Clayton Found Res Injectable soft tissue augmentation materials
EP0331786B1 (de) * 1988-03-11 1994-08-03 CHEMOKOL G.b.R. Ing.-Büro für Kollagenprodukte Verfahren zur Herstellung von Kollagenmembranen für Hämostase, Wundbehandlung und Implantate
US5110604A (en) * 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5024841A (en) * 1988-06-30 1991-06-18 Collagen Corporation Collagen wound healing matrices and process for their production
US5138030A (en) * 1989-10-10 1992-08-11 Pachence James M Process for extracting type I collagen form an avian source, and applications therefor
US5206028A (en) * 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
US5204382A (en) * 1992-02-28 1993-04-20 Collagen Corporation Injectable ceramic compositions and methods for their preparation and use
US5523291A (en) * 1993-09-07 1996-06-04 Datascope Investment Corp. Injectable compositions for soft tissue augmentation

Also Published As

Publication number Publication date
ATE210992T1 (de) 2002-01-15
KR100333088B1 (ko) 2002-09-12
JP3596892B2 (ja) 2004-12-02
ES2169085T3 (es) 2002-07-01
BR9407420A (pt) 1996-11-12
EP0717634A1 (de) 1996-06-26
US5705488A (en) 1998-01-06
WO1995007095A1 (en) 1995-03-16
DE69429522T2 (de) 2002-08-01
CN1142789C (zh) 2004-03-24
CA2170754A1 (en) 1995-03-16
KR960704562A (ko) 1996-10-09
JPH09502372A (ja) 1997-03-11
CN1133562A (zh) 1996-10-16
CA2170754C (en) 2006-07-11
PT717634E (pt) 2002-06-28
US5523291A (en) 1996-06-04
DK0717634T3 (da) 2002-04-15
EP0717634B1 (de) 2001-12-19
AU7685794A (en) 1995-03-27
AU675879B2 (en) 1997-02-20
EP0717634A4 (de) 1999-03-17

Similar Documents

Publication Publication Date Title
DE69429522D1 (de) Injizierbare zusammensetzungen zur vergrösserung von weichgewebe
DK0831884T3 (da) Anvendelse af knoglemorfogenetiske proteiner til heling og reparation af bindevævsbinding
CA2030518A1 (en) Osteoinductive compositions
GB9503492D0 (en) Chemical product
ATE238417T1 (de) Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
EP0339607A3 (en) Composition for repair of cartilage and bone and method for their preparation as skeletal tissue implant
DK0592562T3 (da) BMP-9-præparater
ATE177954T1 (de) Verfahren zur behandlung von knochengeweben und implantierbare biomaterialien dafür
ATE250423T1 (de) Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel
DE69429450D1 (de) Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
ATE74010T1 (de) Injizierbare zusammensetzung zur wiederherstellung von knochen.
ATE120203T1 (de) Methoden und zusammensetzungen für heilung von knochen.
DE69418865D1 (de) Osteoblastswachstumfordernde zusammensetzungen die pdgf und vitamin-d enthalten
ATE64537T1 (de) Mark-/kollagen-/mineralmatrix zur bekaempfung von knochendefekten.
Hedner et al. Efficacy of bone morphogenetic protein (BMP) with osteopromotive membranes–an experimental study in rat mandibular defects
ATE255920T1 (de) Methoden und zusammensetzungen zur heilung und reparatur von gelenkknorpeln
DE59002413D1 (de) Resorbierbare Knochenkeramik auf Basis von Tricalciumphosphat.
ATE322282T1 (de) Knochen morphogenetisches protein und fibroblasten wachstumsfaktor enthaltende zusammensetzungen und methoden zur induzierung der kardiogenese
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
RU94036600A (ru) Способ устранения посттравматических дефектов костей скулоглазничной области

Legal Events

Date Code Title Description
8364 No opposition during term of opposition